Achievement of sustained drug-free remission in GCA is rare; relapses and the need for GC boluses were associated with requiring long-term GC treatment.

Administer medications via the oral route when possible ... and enteral nutrition delivery method (e.g., continuous or bolus). Liquid dosage formulations are preferred. Elixirs and suspensions ...

The administration of salbutamol was accompanied with 5 mg/kg intravenous hydrocortisone as a bolus administered over 3 mins immediately followed by an infusion of the study drug administered over ...

China has become a key piece of Foresite Capital’s investment and company formation strategy. During the J.P. Morgan Healthcare Conference, Managing Director Michael Rome shared his thoughts on why ...

US FDA clears expanded use of Alcresta Therapeutics’ RELiZORB cartridge for paediatric patients 1 year of age and older: Waltham, Massachusetts Friday, January 17, 2025, 17:00 H ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the risks of substance abuse disorders, psychosis, infections, some kinds of ...

Drug testing may be required as a prerequisite for some jobs. State laws may dictate when private employers can require drug tests and how they can use the results. Job candidates for “safety ...

Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in patients with normal or impaired renal ...

While medication can provide symptom relief, it does not necessarily address underlying maladaptive behaviors, and is therefore considered by many clinicians and adjunct to treatment, rather than ...

Need to identify a tablet or capsule? Use our Pill Identifier to find the name and image of an unknown prescription or over-the-counter medication. Start by entering details like pill imprint code ...

Amgen today announced that the U.S. Food and Drug Administration (FDA) has approved LUMAKRAS® (sotorasib) in combination with Vectibix® (panitumumab) for the treatment of adult patients with KRAS G12C ...

Elevance Health Q3 2024 misses EPS estimates, stock rises ...